VeriMom¿Es ginsenoside re seguro durante el embarazo?
Limited reproductive/embryotoxicity evidence exists in non‑clinical studies (in vitro whole‑embryo culture and other lab studies reporting embryotoxic/teratogenic effects of isolated ginsenosides), but no harmonised CLP classification or convincing in‑vivo developmental toxicity data were found; CIR materials list ginsenosides as components of Panax extracts but do not give a harmonised reproductive hazard. Sources: PubMed embryotoxicity studies and reviews, CIR panel materials, LactMed review.
Alternativas seguras a ginsenoside re en el embarazo | VeriMom
Related ingredients
Frequently asked questions
- ¿Es ginsenoside re seguro durante el embarazo?
- Limited reproductive/embryotoxicity evidence exists in non‑clinical studies (in vitro whole‑embryo culture and other lab studies reporting embryotoxic/teratogenic effects of isolated ginsenosides), but no harmonised CLP classification or convincing in‑vivo developmental toxicity data were found; CIR materials list ginsenosides as components of Panax extracts but do not give a harmonised reproductive hazard. Sources: PubMed embryotoxicity studies and reviews, CIR panel materials, LactMed review.
- ¿Es ginsenoside re seguro durante la lactancia?
- Human data are lacking; reviews and LactMed note possible estrogenic activity of ginsenosides and advise caution in lactation, but no direct clinical breast‑milk transfer or adverse‑infant reports from topical cosmetic use were found. No harmonised classification or SCCS/CIR adverse conclusion specific to topical use was located.
- ¿Es ginsenoside re seguro para la piel del bebé?
- Hazard and mechanism scores kept the same as adult (no infant‑specific evidence to increase hazard/mechanism). Dermal absorption from cosmetics is expected to be low for a high‑MW saponin like ginsenoside Re (large glycoside), but infant skin permeability is higher so exposure score is increased by +1 for 0–3‑year‑old skin; no direct percutaneous absorption studies for ginsenoside Re in humans/infants were found.
- ¿Cómo puntúa VeriMom a ginsenoside re?
- VeriMom puntúa ginsenoside re en 67/100 (riesgo medio) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a ginsenoside re en el embarazo?
- Consulta nuestra lista de alternativas seguras a ginsenoside re según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.